BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17947799)

  • 21. Endothelin-mediated vasoconstriction in early atherosclerosis is markedly increased in ApoE-/- mouse but prevented by atorvastatin.
    Maguire JJ; Wiley KE; Kuc RE; Stoneman VE; Bennett MR; Davenport AP
    Exp Biol Med (Maywood); 2006 Jun; 231(6):806-12. PubMed ID: 16741003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serine protease inhibitor Serp-1 strongly impairs atherosclerotic lesion formation and induces a stable plaque phenotype in ApoE-/-mice.
    Bot I; von der Thüsen JH; Donners MM; Lucas A; Fekkes ML; de Jager SC; Kuiper J; Daemen MJ; van Berkel TJ; Heeneman S; Biessen EA
    Circ Res; 2003 Sep; 93(5):464-71. PubMed ID: 12919945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plaque rupture after short periods of fat feeding in the apolipoprotein E-knockout mouse: model characterization and effects of pravastatin treatment.
    Johnson J; Carson K; Williams H; Karanam S; Newby A; Angelini G; George S; Jackson C
    Circulation; 2005 Mar; 111(11):1422-30. PubMed ID: 15781753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Critical role of bone marrow angiotensin II type 1 receptor in the pathogenesis of atherosclerosis in apolipoprotein E deficient mice.
    Fukuda D; Sata M; Ishizaka N; Nagai R
    Arterioscler Thromb Vasc Biol; 2008 Jan; 28(1):90-6. PubMed ID: 17962627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced immunoregulatory CD31+ T cells in the blood of atherosclerotic mice with plaque thrombosis.
    Caligiuri G; Groyer E; Khallou-Laschet J; Al Haj Zen A; Sainz J; Urbain D; Gaston AT; Lemitre M; Nicoletti A; Lafont A
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1659-64. PubMed ID: 15933243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced atherosclerotic lesions in P2Y1/apolipoprotein E double-knockout mice: the contribution of non-hematopoietic-derived P2Y1 receptors.
    Hechler B; Freund M; Ravanat C; Magnenat S; Cazenave JP; Gachet C
    Circulation; 2008 Aug; 118(7):754-63. PubMed ID: 18663083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice.
    Wang Y; Zhao X; Jin H; Wei H; Li W; Bu D; Tang X; Ren Y; Tang C; Du J
    Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):173-9. PubMed ID: 18988885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetically determined resistance to collagenase action augments interstitial collagen accumulation in atherosclerotic plaques.
    Fukumoto Y; Deguchi JO; Libby P; Rabkin-Aikawa E; Sakata Y; Chin MT; Hill CC; Lawler PR; Varo N; Schoen FJ; Krane SM; Aikawa M
    Circulation; 2004 Oct; 110(14):1953-9. PubMed ID: 15451791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-dose and fractionated irradiation promote initiation and progression of atherosclerosis and induce an inflammatory plaque phenotype in ApoE(-/-) mice.
    Hoving S; Heeneman S; Gijbels MJ; te Poele JA; Russell NS; Daemen MJ; Stewart FA
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):848-57. PubMed ID: 18514779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atheroprotective and plaque-stabilizing effects of enzymatically modified isoquercitrin in atherogenic apoE-deficient mice.
    Motoyama K; Koyama H; Moriwaki M; Emura K; Okuyama S; Sato E; Inoue M; Shioi A; Nishizawa Y
    Nutrition; 2009 Apr; 25(4):421-7. PubMed ID: 19026522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mast cell degranulator compound 48-80 promotes atherosclerotic plaque in apolipoprotein E knockout mice with perivascular common carotid collar placement.
    Tang YL; Yang YZ; Wang S; Huang T; Tang CK; Xu ZX; Sun YH
    Chin Med J (Engl); 2009 Feb; 122(3):319-25. PubMed ID: 19236812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and feasibility of transendocardial autologous bone marrow cell transplantation in patients with advanced heart disease.
    Fuchs S; Kornowski R; Weisz G; Satler LF; Smits PC; Okubagzi P; Baffour R; Aggarwal A; Weissman NJ; Cerqueira M; Waksman R; Serrruys P; Battler A; Moses JW; Leon MB; Epstein SE
    Am J Cardiol; 2006 Mar; 97(6):823-9. PubMed ID: 16516583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rosiglitazone promotes atherosclerotic plaque stability in fat-fed ApoE-knockout mice.
    Zhou M; Xu H; Pan L; Wen J; Liao W; Chen K
    Eur J Pharmacol; 2008 Aug; 590(1-3):297-302. PubMed ID: 18602628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nebivolol, but not metoprolol, improves endothelial function of the corpus cavernosum in apolipoprotein e-knockout mice.
    Baumhäkel M; Schlimmer N; Büyükafsar K; Arikan O; Böhm M
    J Pharmacol Exp Ther; 2008 Jun; 325(3):818-23. PubMed ID: 18364472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo MR imaging of bone marrow cells trafficking to atherosclerotic plaques.
    Qiu B; Gao F; Walczak P; Zhang J; Kar S; Bulte JW; Yang X
    J Magn Reson Imaging; 2007 Aug; 26(2):339-43. PubMed ID: 17623878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of human smooth muscle cell progenitors in atherosclerotic plaque development and composition.
    Zoll J; Fontaine V; Gourdy P; Barateau V; Vilar J; Leroyer A; Lopes-Kam I; Mallat Z; Arnal JF; Henry P; Tobelem G; Tedgui A
    Cardiovasc Res; 2008 Feb; 77(3):471-80. PubMed ID: 18006460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mobilization of haematopoietic and non-haematopoietic cells by granulocyte-colony stimulating factor and vascular endothelial growth factor gene therapy in patients with stable severe coronary artery disease.
    Wang Y; Ripa RS; Jørgensen E; Hesse B; Mortensen S; Kastrup J
    Scand Cardiovasc J; 2007 Dec; 41(6):397-404. PubMed ID: 17924284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
    Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
    Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice.
    Custodis F; Baumhäkel M; Schlimmer N; List F; Gensch C; Böhm M; Laufs U
    Circulation; 2008 May; 117(18):2377-87. PubMed ID: 18443241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced external counterpulsation promotes growth cytokines-mediated myocardial angiogenesis in a porcine model of hypercholesterolemia.
    Luo JY; Wu GF; Xiong Y; Chen GW; Xie Q; Yang DY; He XH; Zhang Y; Liu DH; Wang KJ; Ma H; Zheng ZS; DU ZM
    Chin Med J (Engl); 2009 May; 122(10):1188-94. PubMed ID: 19493469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.